Accelerated evolution of brain atrophy and “black holes” in MS patients with APOE‐ε4
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Apolipoprotein E (APOE)–ε4 has been associated with an unfavorable course of multiple sclerosis (MS). The mechanisms responsible for this are unclear, although cross‐sectional MRI demonstrated a higher extent of “black holes” (BHs) in such patients. Here, we have studied the impact of the APOE genotype on both the longitudinal evolution of focal (BH ratio) and global (brain volume change [BVC]) brain tissue damage. Ninety‐nine MS patients underwent ApoE genotyping, clinical examination, and magnetic resonance imaging at baseline and after 2.7 ± 1.1 years to assess lesion load (LL) and BVC. In APOE‐ε4 patients, the annual reduction in brain volume was fivefold higher (−0.65 ± 0.61%) than in those without APOE‐ε4 (−0.13 ± 0.36%; p = 0.0001). At baseline, T 2 LL and T 1 LL were non‐significantly higher in ε4 carriers, despite a shorter disease duration and absence of significant clinical differences. During follow‐up, T 1 LL increased from 1.2 ± 2.3ccm to 1.7 ± 2.7ccm in the ε4 group, although T 2 LL did not change, leading to a significantly higher increase in the BH ratio [(T 1 LL/T 2 LL) × 100] from 5.5 to 12.4% (p = 0.005). BH ratio remained almost constant in non‐ε4 patients (5.0 vs 5.7%). Accelerated brain tissue loss and a higher proportion of lesions evolving into BH therefore provide magnetic resonance imaging evidence for more pronounced tissue destruction in MS patients with APOE‐ε4. Ann Neurol 2004
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.
Hixson, J., & Vernier, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43176-1 · Cited by 2,933
Peterson, J. W., Bö, L., Mörk, S., Chang, A., & Trapp, B. D. (2001) · Annals of Neurology · doi:10.1002/ana.1123 · Cited by 1,403
Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis
van Walderveen, M. A. A., Kamphorst, W., Scheltens, P., van Waesberghe, J. H. T. M., Ravid, R., Valk, J., Polman, C. H., & Barkhof, F. (1998) · Neurology · doi:10.1212/wnl.50.5.1282 · Cited by 656
Neuroplasticity in Alzheimer's disease
Teter, B., & Ashford, J. W. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10441 · Cited by 170
Cited by
The measurement and clinical relevance of brain atrophy in multiple sclerosis
Bermel, R. A., & Bakshi, R. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70349-0 · Cited by 456
Risk factors for progression of brain atrophy in aging: Six-year follow-up of normal subjects
Enzinger, C., Fazekas, F., Matthews, P. M., Ropele, S., Schmidt, H., Smith, S., & Schmidt, R. (2005) · Neurology · doi:10.1212/01.wnl.0000161871.83614.bb · Cited by 404
Self-citationRisk factors for and management of cognitive dysfunction in multiple sclerosis
Benedict, R. H. B., & Zivadinov, R. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.61 · Cited by 370
Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
Riddell, D. R., Zhou, H., Atchison, K., Warwick, H. K., Atkinson, P. J., Jefferson, J., Xu, L., Aschmies, S., Kirksey, Y., Hu, Y., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1972-08.2008 · Cited by 346
“…2000), and stroke (Schneider et al., 2005), as well as influencing the age of onset of other neurodegenerative diseases such as Parkinson’s disease (Pankratz et al., 2006), multiple sclerosis (Fazekas et al., 2001; Enzinger et al., 2004) and amyotrophic lateral sclerosis (Moulard et al., 1996).”
BackgroundApolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration
Malek, G., Johnson, L. V., Mace, B. E., Saloupis, P., Schmechel, D. E., Rickman, D. W., Toth, C. A., Sullivan, P. M., & Rickman, C. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503015102 · Cited by 284
Metadata
- Authors
- Enzinger, C., Ropele, S., Smith, S., Strasser‐Fuchs, S., Poltrum, B., Schmidt, H., Matthews, P. M., & Fazekas, F.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2004-03-21
- Volume
- 55
- Issue
- 4
- Pages
- 563-569
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2066690437
- Cited by
- 112
- References
- 5
- FWCI
- 10.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Accelerated evolution of brain atrophy and “black holes” in MS patients with APOE‐ε4. https://app.cochat.ai/papers/10.1002/ana.20027
- The paper
- Enzinger, C., Ropele, S., Smith, S., Strasser‐Fuchs, S., Poltrum, B., Schmidt, H., Matthews, P. M., & Fazekas, F. (2004). Accelerated evolution of brain atrophy and “black holes” in MS patients with APOE‐ε4. Annals of Neurology. https://doi.org/10.1002/ana.20027
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.